← Back to Search

Contingency Management for Alcoholism (Peth Trial)

N/A
Recruiting
Led By Sheila Alessi, Ph.D.
Research Sponsored by UConn Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Peth Trial Summary

This trial will study whether providing reinforcement (in the form of vouchers) for negative alcohol tests and treatment attendance will increase the proportion of participants who respond to treatment for alcohol use disorders.

Who is the study for?
This trial is for individuals with an alcohol use disorder who are starting intensive outpatient treatment. It's not suitable for those with conditions that could interfere with their participation in the study.Check my eligibility
What is being tested?
The study tests if adding a reward system (Contingency Management) to standard care improves attendance and reduces alcohol consumption in patients. Participants will either receive standard care or standard care plus rewards for attending treatment and providing alcohol-free blood samples.See study design
What are the potential side effects?
Since this trial involves behavioral interventions rather than medications, traditional side effects are not expected. However, participants may experience stress or disappointment when they do not meet the criteria for receiving rewards.

Peth Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alcohol abstinence
Group attendance

Peth Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental GroupExperimental Treatment2 Interventions
Standard care plus contingency management
Group II: Control GroupActive Control1 Intervention
Standard care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Contingency management
2006
Completed Phase 4
~960
Standard care
2005
Completed Phase 3
~9260

Find a Location

Who is running the clinical trial?

UConn HealthLead Sponsor
211 Previous Clinical Trials
60,471 Total Patients Enrolled
19 Trials studying Alcoholism
3,402 Patients Enrolled for Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
802 Previous Clinical Trials
1,365,295 Total Patients Enrolled
424 Trials studying Alcoholism
985,718 Patients Enrolled for Alcoholism
Sheila Alessi, Ph.D.Principal Investigator - UConn Health
UConn Health
3 Previous Clinical Trials
240 Total Patients Enrolled
1 Trials studying Alcoholism
120 Patients Enrolled for Alcoholism

Media Library

Contingency management Clinical Trial Eligibility Overview. Trial Name: NCT04064463 — N/A
Alcoholism Research Study Groups: Experimental Group, Control Group
Alcoholism Clinical Trial 2023: Contingency management Highlights & Side Effects. Trial Name: NCT04064463 — N/A
Contingency management 2023 Treatment Timeline for Medical Study. Trial Name: NCT04064463 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being enrolled in this research project?

"Affirmative. As per the clinicaltrials.gov records, this clinical trial is actively seeking patients for enrollment and has been since January 22nd 2020. The latest update was on June 1st 2022 and 150 patients are being recruited from a single site."

Answered by AI

Are there any vacancies to participate in this research project at the moment?

"Affirmative. Per the clinicaltrials.gov database, this medical study is recruiting patients - first posted on January 22nd 2020 and last edited June 1st 2022 - with a need for 150 enrollees at one site."

Answered by AI
~8 spots leftby Aug 2024